Kristie L. Kahl
CURE Magazine
Contact Kristie
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Kristie:
Educated Patient® Prostate Cancer Summit Genetics & Genomics Panel: May 21, 2022
Watch Dr. Veda N. Giri, Dr. Umang Swami and Sue Friedman answer questions about genetics and genomics during the CURE Educated Patient Prostate Cancer Summit. → Read More
Discussing the Importance of Genetic Counseling in Women’s Cancer
As part of its Speaking Out video series, CURE spoke with Dr. Navya Nair, on behalf of the Foundation for Women’s Cancer, about genetics in women’s cancer. → Read More
CURE Remembers MJH Life Sciences Founder Michael J. Hennessy
Hennessy, 61, founded MJH Life Sciences, the publisher of CURE Magazine, more than 20 years ago. → Read More
The Basics of von Hippel-Lindau Disease
CURE spoke with Stacy Lloyd, board member of the VHL Alliance, to better understand VHL and its impact on cancer. → Read More
A New Way to Fight Triple-Negative Breast Cancer Arrives
Even as chemotherapy, surgery and radiation remain treatment mainstays, immunotherapy is ready to take the stage. → Read More
How The Community Can Help Combat Access to Lung Cancer Screening, Care Issues
CURE® spoke with Dr. David Cooke, on behalf of the American Lung Association, on addressing racial disparities in lung cancer screening and care. → Read More
FDA Approves Blenrep to Treat Relapsed/Refractory Multiple Myeloma
The Food and Drug Administration approved Blenrep to treat patients with relapsed/refractory multiple myeloma. → Read More
CURE Community Vlog: Cancer Diagnoses Can Be a Distant Memory
“When time passes, and you look back it seems like a distant memory.” → Read More
CURE Community Vlog: One Patient's Journey With Merkel Cell Carcinoma
“You have to speak up. What you don’t say is the most predictive of the care you don’t get.” → Read More
Living With a Lung Cancer Diagnosis
Miranda Goff, from the Go2 Foundation for Lung Cancer, discusses resources available for those living with a lung cancer diagnosis. → Read More
Exciting Therapeutic Options for Small Cell Lung Cancer
Andrew Ciupek, from the GO2 Foundation for Lung Cancer, discusses what is on the horizon for patients with small cell lung cancer. → Read More
Talking About Direct-To-Consumer Genetic Testing
Lisa Schlager, vice president of public policy at FORCE: Facing Our Risk Empowered, offered background on the differences between genetic testing and a direct-to-consumer test, and why patients should be careful when using over-the counter genetic tests. → Read More
Joining a Clinical Trial
Neena Kennedy, from the Leukemia and Lymphoma Society, offers advice on how to find out about and join clinical trials. → Read More
CURE's Clinical Trial Corner: February 2020
Here is a list of the recent trial initiations that occurred within the cancer space in February. → Read More
FDA Approves Keytruda for High-Risk, Non-Muscle Invasive Bladder Cancer
The Food and Drug Administration approved Keytruda for the treatment of patients with Bacillus Calmette-Guerin–unresponsive, high-risk, non-muscle invasive bladder cancer. → Read More
Video Series Offers Support to Cancer Caregivers
The American Cancer Society launched a video series to offer support for caregivers to address their questions and concerns throughout their loved one’s cancer journey. → Read More
What You Need to Know About the FDA's Approval of Xtandi in Prostate Cancer
Men with metastatic castration-sensitive prostate cancer will now have a fourth treatment option to consider. → Read More
CURE's Clinical Trial Corner: December 2019
Here is a list of the recent trial initiations that occurred within the cancer space in December. → Read More
Addressing Nutrition in Patients with Kidney Cancer
Nutrition plays a key role in kidney cancer; however, the need to address it is still unmet. → Read More
CURE's Clinical Trial Corner: September 2019
Here is a list of the recent trial initiations that occurred within the cancer space in September. → Read More